Latest Patents News

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) reported net sales of US$30.3 million for its FDA-approved cellular therapy Ryoncil in the March quarter, bringing total revenue since launch close to US$100 million. Strong sales in February and March offset January’s seasonal dip.

Memphasys Limited (ASX: MEM) announced an investor webinar and released an updated presentation detailing its transition from early-stage commercialisation to scaling global revenues, highlighting multi-market sales, recurring cartridge revenue, and regulatory progress.

Advanced Innergy Holdings Ltd (ASX:AIH) has entered an exclusivity deed with Matrix Composites & Engineering Ltd (ASX:MCE) following a non-binding indicative offer to acquire all MCE shares at $0.40 each. The exclusivity period extends to 28 April 2026, allowing AIH to negotiate binding terms exclusively as part of its strategy to expand in subsea technologies and manufacturing in the Asia-Pacific region.

Janus Electric has appointed Lynx Advisors and Spark Plus to bolster its capital strategy and investor engagement while settling longstanding disputes with Kjøller A/S. The company also ends its agreement with EVUNI, opening new partnership opportunities.

Way2VAT has successfully raised A$2.6 million through a share placement, aiming to repay short-term debt and fund its strategic expansion plans. Investors have shown strong support, agreeing to a six-month escrow on their shares.

AML3D has successfully commissioned a large-scale ARCEMY X 6700 metal 3D printer at US defence supplier FasTech, completing a $1.7 million order and signalling a strategic expansion in the US industrial manufacturing market.

Since its October 2025 ASX IPO, Temas Resources has made significant strides in commercialising its proprietary metallurgical technology and advancing its Québec mineral projects, supported by solid financial reserves.

St George Mining has partnered with Boston Metal to trial a cutting-edge molten oxide electrolysis technology at its Araxá Project, aiming to revolutionise niobium production with lower costs and emissions.

Racura Oncology has enrolled the first patient in its Phase 1 HARNESS-1 trial, testing RC220 alongside osimertinib to tackle resistance in EGFR-mutant non-small cell lung cancer. This milestone sets the stage for a multi-centre study aiming to improve treatment outcomes.

Latrobe Magnesium has locked in a US$2 million non-dilutive prepayment from its US distribution partner to accelerate commissioning of its Demonstration Plant, aiming for first magnesium deliveries in late 2026.

Cleo Diagnostics has completed blood sample collection for its pivotal U.S. clinical trial, advancing its Pre-Surgical Ovarian Cancer Test closer to FDA submission.

Bayan Mining and Minerals has secured membership in the U.S. Defense Industrial Base Consortium, opening doors to strategic partnerships and funding for its rare earth technologies, including a patented yttrium upgrade process. This move positions Bayan at the forefront of efforts to secure critical mineral supply chains vital to U.S. national security.